•  
  •  
  •  
  •  
  •  

In 2015, there were 214 million recorded cases of malaria across the globe. Of those infected, approximately 483,000 victims died of the disease. Since infection is spread by mosquitoes, malaria is extremely easy to contract. To make matters worse, diagnosing the disease has proven difficult, and many cases have gone misdiagnosed because of the complexity of the procedure. For decades, the medical world has been desperately attempting to generate a vaccine for this deadly disease, but all efforts have yielded negative results.

A glimmer of hope begins to light the way, though, as researchers at Sight Diagnostics, an Israeli medical device developer, has discovered a way to diagnose the disease in its earliest stages before it has had time to claim lives. With their newly developed technology, medical leaders are hopeful for a brighter future, one that doesn’t contain malaria.

Sight Diagnostics Sheds Light on Malaria Epidemic

Sight Diagnostics is a company that specializes in developing medical devices which use computer vision technology to effectively diagnose blood diseases. This innovative computer technology has lead to some astounding breakthroughs, the possible solution to Malaria being just one of them. The malaria device is called the Parasite Platform, and it’s so simple to use, medical professionals are surprised that someone didn’t come up with it sooner!

The Device to Diagnose the Disease

The Parasite Platform is currently being used by medical professionals all over the world to diagnose malaria. The significant breakthrough here is that it can diagnose the disease quickly and in a cost-efficient way. Since so many cases of malaria have gone untreated because of the costly, timely, and inaccurate diagnoses process, this device could well change the course of the malaria epidemic completely. The Parasite Platform is easy to use and has the most accurate results to date.

To see how the Parasite Platform works, check out this video:

A Global Solution

Africa has been hit hard by malaria, recording a $12 million annual loss due to the negative impact it’s had on tourism, increased medical care costs, and lost work force. Additionally, 90% of the deaths cited above were within Africa, so naturally Sight has geared much of their product distribution towards this region of the world. The devices are currently being sold and used successfully across India, Africa, and Europe, and according to Sight, this could be the biggest innovation for malaria development since the introduction of PCR.

On the heels of the Parasite Platform success, Sight has continued to develop their technology so they can develop and market a point-of-care complete blood count device that can be used in ordinary hospitals and doctors’ offices. Other innovations are in the research stages, and Sight Diagnostics may unveil more groundbreaking and life-saving measures in the near future.


  •  
  •  
  •  
  •  
  •  

Comments